Replies to post #144512 on Elite Pharmaceuticals Inc (ELTP)

[tangerine]

That is where it is really going to get interesting. We all know the product works. Note how no one has anything legitimately bad to say about the technology. We all know it works and we all know it will be approved. The question becomes how fast can they assembly line them out the door. Seems it will be very fast.

[Mocha Jet]

**** Elite Pharmaceuticals Conference Call Questions ****

Those participating in ELTP’s Conference Call Q&A session are typically allowed to ask one question following ELTP management’s opening statements. To make the most of this Q&A opportunity, suggest that we come up with a list to share of top questions to ask:

(Copy/paste the latest posted list and add your question(s) at the end of the list)

1. Clinical Trials

a. When can we expect Lifetree abuse liability results?

b. How long do you expect these trials to last?

c. How many products are tested at a time in these studies?

d. Is the plan to file upon successful results?

e. Is it possible to get the data in the form of a Pie Chart to help a layperson understand the actual trial results?

f. Would the FDA allow ELTP to HAL trial multiple products together?

2. Lincoln Park Capital (LPC) Securities Funding

a. How many have been placed with LPC exclusive of the free shares?

b. How much money was generated for the shares?

c. How much of the money has been spent?

d. What was it used on?

3. Any plans for Eli-154?

4. Updates on Eli-201 and Eli 202?

5. What's going on with the three drugs in Scale up?

6. Any generics moving up the ladder to commercialization?

7. Given the share price hovering at the “worst case” scenario, and far below the 2.10-2.75 levels that were indicated as the more reasonable valuation range at that time, why are you comfortable with the valuation as reflective of Elite’s future?

8. I understand we had an agreement with Epic for 8 drugs where we get a 15% profit split. I also understand that we are no longer proceeding with the last 7 drugs. However, the first and only drug has been filed with the FDA for 3 1/2 years now and we haven't heard anything. Do you have any updates on this?

9. Eli 200

a. Any FDA feedback?

b. Update on NDA ART filing progess.

c. Zogenix just got their ADT Zohydro approved without an efficacy trial. Do you think this zohydro decision will have any bearing on Elite's ELI 200 requiring an efficacy trial?

10. Status update on the arbitration of Phentermine with Precision Dose?

11. Eli 216

a. Given that Elite's generic NDA ART line takes less time and money to bring to market then Elite's once daily Eli 216 product, can you speak to what the current plans are for this product say for instance to partner a combo Eli 201 and 216 together and how quickly you are planning to move forward with this product as there is no other once daily abuse resistant product on the market?

b. What was the reason(s) for not beginning the Eli 216 trials in March 2014?

12.